Compare
Elevance Health, Inc. vs Centene Corp vs Humana Inc vs UnitedHealth Group Inc
| Latest fiscal year | Elevance Health, Inc. ELV | Centene Corp CNC | Humana Inc HUM | UnitedHealth Group Inc UNH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $199.12B | $194.78B | $129.66B | $447.57B |
| Revenue growth (YoY) | +12.5% | +19.4% | +10.1% | +11.8% |
| Gross margin | n/a | 7.3% | n/a | n/a |
| Operating margin | 3.6% | -3.9% | 2.1% | 4.2% |
| Net margin | 2.8% | -3.4% | 0.9% | 2.7% |
| Net income | $5.66B | -$6.67B | $1.19B | $12.06B |
| EPS (Diluted) | $25.21 | -$13.53 | $9.84 | $13.23 |
| Operating cash flow | $4.29B | $5.09B | $921.00M | $19.70B |
| Free cash flow | $3.17B | $4.32B | $375.00M | $16.07B |
| Cash & equivalents | $9.49B | $17.89B | $4.20B | $24.36B |
| Total assets | $121.49B | $76.75B | $48.91B | $309.58B |
| Total liabilities | $77.47B | $56.69B | $31.17B | $207.88B |
| Shareholders' equity | $43.88B | $20.03B | $17.66B | $100.09B |
| Return on year-end equity | 12.9% | -33.3% | 6.7% | 12.0% |
| Shares outstanding | 220.72M | 491.76M | n/a | 906.00M |
Revenue, most recent five fiscal years
| Fiscal year | Elevance Health, Inc. | Centene Corp | Humana Inc | UnitedHealth Group Inc |
|---|---|---|---|---|
| Latest | $199.12B Ended 2025-12-31 | $194.78B Ended 2025-12-31 | $129.66B Ended 2025-12-31 | $447.57B Ended 2025-12-31 |
| 1 year earlier | $177.01B Ended 2024-12-31 | $163.07B Ended 2024-12-31 | $117.76B Ended 2024-12-31 | $400.28B Ended 2024-12-31 |
| 2 years earlier | $171.34B Ended 2023-12-31 | $154.00B Ended 2023-12-31 | $106.37B Ended 2023-12-31 | $371.62B Ended 2023-12-31 |
| 3 years earlier | $156.59B Ended 2022-12-31 | $144.55B Ended 2022-12-31 | $92.87B Ended 2022-12-31 | $324.16B Ended 2022-12-31 |
| 4 years earlier | $138.64B Ended 2021-12-31 | $125.98B Ended 2021-12-31 | $83.06B Ended 2021-12-31 | $287.60B Ended 2021-12-31 |